Masset Zoé, Gunaratnam Sathursha, Millette Mathieu, McFarland Lynne V, Lacroix Monique
INRS Armand-Frappier Health Biotechnology Research Centre, Research Laboratories in Sciences, Applied to Food (RESALA), MAPAQ Research Chair in food safety and quality, Canadian Irradiation Centre, Institute of Nutrition and Functional Foods (INAF), 531 des Prairies Blvd, Laval, QC H7V 1B7, Canada.
Bio-K Plus International Inc., 495 Armand-Frappier Blvd, Laval, QC H7V 4B3, Canada.
J Appl Microbiol. 2023 Mar 1;134(3). doi: 10.1093/jambio/lxad047.
Clostridioides difficile infections (CDI) are a major cause of morbidity and mortality in hospitalized patients. A probiotic formulation (Bio-K+) comprised of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacti. rhamnosus CLR2 strains have been shown to reduce the incidence of CDI and antibiotic-associated diarrhea (AAD). This research aims to therefore elucidate the mechanism of action of the three probiotic strained against C. difficile R20291, independently of the acidification of the environment. .
Antitoxin activity was evaluated using ELISA method and the expression of C. difficile genes was evaluated using transcriptomic analysis in co-culture assays conducted in a bioreactor allowing precise control of the pH. The fermentation results demonstrated a decrease for toxin A and many genes directly related to C. difficile virulence were underexpressed in the co-cultures.
The lactobacilli tested could have a role in the motility, the quorum sensing (QS), the survival of the spores, and the germination potential of the spores, which are essential elements for the virulence of C. difficile. .
艰难梭菌感染(CDI)是住院患者发病和死亡的主要原因。一种由嗜酸乳杆菌CL1285、干酪乳杆菌LBC80R和鼠李糖乳杆菌CLR2菌株组成的益生菌制剂(Bio-K+)已被证明可降低CDI和抗生素相关性腹泻(AAD)的发生率。因此,本研究旨在阐明这三种益生菌菌株对艰难梭菌R20291的作用机制,而不依赖于环境酸化。
在可精确控制pH值的生物反应器中进行共培养试验,采用ELISA法评估抗毒素活性,采用转录组分析评估艰难梭菌基因的表达。发酵结果表明,毒素A减少,且在共培养中许多与艰难梭菌毒力直接相关的基因表达下调。
所测试的乳酸杆菌可能在艰难梭菌的运动性、群体感应(QS)、孢子存活及孢子萌发潜力方面发挥作用,而这些是艰难梭菌毒力的关键要素。